Ecot, Richard C.
HRN: 21-40-03 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/01/2022
06/08/2022
IV
600mg
Q6
Abscess Left Chest
Waiting Final Action
Indication: Empirical Escalation Type of Infection: PneumoniaBone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes